Clinical Trial Update: Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI for endometriosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• [F-18] Fluoroestradiol (FES) PET/MRI (fluoroestradiol)

Snippet

Sponsor: Annie (Annie) T. Packard | Conditions: Endometriosis | Phase 1, Phase 2 | Status: WITHDRAWN